Skip to main content
. 2022 Sep 14;13:975233. doi: 10.3389/fimmu.2022.975233

Figure 3.

Figure 3

(A) ΔiC8-RQR8 (Elafin1a promoter), Rapa.ΔiC9-ΔCD19 (Human-PGK promoter) lentiviral constructs, and proteins diagram; ΔiC8 and Rapa.ΔiC9 are activatable by the BB homodimerizer or sirolimus, respectively. (B) Average with SD of the percentage of killing in non-transduced Jurkat cells, or Jurkat cells gene-modified to express ΔiC8-RQR8, Rapa.ΔiC9-ΔCD19, or both (N: 3-7 experiments) after overnight exposure to the BB homodimerizer at 100nM, sirolimus (siro) 25 ng/mL or both.